Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9BPA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,220
Award facts
- Contract value 100% obligated
- $14,220.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Dupixent 300 mg/2 mL pen injections with a firm fixed price ceiling value of $14,220.26. The delivery order is non-set-aside and competitively awarded, with an ultimate completion date of December 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving the Defense Health Agency and military healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical supply needs through open competition, ranging from small-value transactions to substantial orders. Under the SPE2DX IDC, AmerisourceBergen supplies specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26F9BPA?
SPE2DR26F9BPA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26F9BPA worth?
The government has obligated $14,220 on SPE2DR26F9BPA.
Is contract SPE2DR26F9BPA an order under another contract?
Yes. SPE2DR26F9BPA is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9BPA competed?
The extent of competition for SPE2DR26F9BPA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award